Stockreport

Syndax: Early Commercial Momentum Points Toward Strong 2026 Growth [Seeking Alpha]

Syndax Pharmaceuticals, Inc.  (SNDX) 
Last syndax pharmaceuticals, inc. earnings: 3/3 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.syndax.com
PDF SNDX's commercial ramp is accelerating, with Revuforj prescriptions up 25%, and management is confident cash reserves will fund operations to profitability. 2026 reve [Read more]